While cholesterol efflux increased in response to simvastatin , bezafibrate and combination treatment ( +12 to +23 % ; anova , P = 0.001 ) , HDL antioxidative capacity ( P = 0.23 ) and HDL anti-inflammatory capacity ( P = 0.15 ) did not change significantly .